The approach to limit APP translation can be viewed as a useful anti-amyloid strategy especially in older Down syndrome (DS) individuals, over age 40, who express three copies of the chromosome 21 gene set (including APP) and who suffer an Alzheimer’s disease (AD)-like dementia confounded often by epileptic seizures [1,3]. This evidence concerns the gene APP and Alzheimer disease.